The global sales of clinical information system is estimated to be worth USD 1,207.0 million in 2024 and anticipated to reach a value of USD 2,412.8 million by 2034. Sales are projected to rise at a CAGR of 8.0% over the forecast period between 2024 and 2034. The revenue generated by Clinical Information System in 2023 was USD 1,117.6 million. The industry is anticipated to exhibit a Y-o-Y growth of 7.4% in 2024.
A CIS is a combined technology platform used by healthcare professionals for managing patient data. These integrated systems consolidate patient records, diagnosis, treatment plans, and test results for efficiency in decision-making and improved healthcare.
Applications of CIS include, electronic health records, patient management systems, and clinical decision support. The driving factors toward the adoption of CIS include improved patient safety, regulatory compliance, enhancement in operational efficiency, cost reduction, better coordination of care, and an increased demand for real-time access to accurate health information for clinicians and patients alike.
Global Clinical Information System Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 1,117.6 million |
| Estimated Size, 2024 | USD 1,207.0 million |
| Projected Size, 2034 | USD 2,412.8 million |
| Value-based CAGR (2024 to 2034) | 8.0% |
The CIS, as an integrated platform, that manages and stores patient data for supporting healthcare practitioners. Clinical information system aid healthcare practitioners in staffing and streamlining workflow processes, it also aid them in making accurate and informed decisions, in regards to their organization.
Several factors contribute to the increasing adoption of CIS among healthcare professionals. These include needs for improved patient care, regulatory requirements such as meaningful use standards, and the drive for operational efficiency. These system assists in managing rising operational cost in healthcare facilities, improved patient outcome and making data driven decision. Integration of predictive analytics for decision support are few of the recent advancements in the clinical information system.
The forecast period anticipates substantial growth in the clinical information system industry, with an incremental opportunity of USD 1,205.8 million. Projections indicate that the market will expand to 2.0 times its current value by 2034.
The introduction of cloud-based solutions promotes better security of data, scalability, and accessibility to healthcare professionals even from remote areas. Interoperability between different systems is also improving, allowing for seamless exchange of data across organizations in healthcare. These developments mark the continued growth in the adoption of CIS in healthcare.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Comparative analysis of fluctuations in compound annual growth rate (CAGR) for the global clinical information system market between 2023 and 2024 on six months basis is shown below. By this examination, major variations in the performance of these markets are brought to light, and also trends of revenue generation are captured hence offering stakeholders useful ideas on how to carry on with the market's growth path in any other given year. January through June covers the first part of the year called half1 (H1), while half2 (H2) represents July to December
The table presents the expected CAGR for the global clinical information system market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 8.7%, followed by a slightly slower growth rate of 8.4% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 8.7% (2023 to 2033) |
| H2 | 8.4% (2023 to 2033) |
| H1 | 8.0% (2024 to 2034) |
| H2 | 7.5% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 8.0% in the first half and decrease moderately at 7.5% in the second half. In the first half (H1) the market witnessed a decrease of 70 BPS while in the second half (H2), the market witnessed a decrease of 90 BPS.
Growing Demand of Digital Health Tools for offering better Connected Care to the Geriatric Population Anticipates the Growth of the Market
Increasing demand for digital health tools, offering better connected care among the geriatric population propels the growth of the market. Elderly patients continuously have to maintain and monitor multiple chronic diseases with the help of coordinated care.
Digital health tools, assists healthcare professionals to provide personalized, real-time care to this population. These tools are integrated into the CIS platforms, which collect data from several sources, such as wearable devices, home monitoring systems, and EHRs. These data enable healthcare professionals for monitoring and adjusting treatments efficiently.
The increased focus on connected care for older adults anticipates the growth in adoption of CIS solutions. For instance, according to an article published by Australian Digital Health Agency in August 2023, Digital Health Agency in Australia has launched the phase of the Aged Care Industry Offer. This offer targets Clinical Information and Electronic Medication Management System software developers for increasing the number of compliant products capable of connecting with My Health Record.
With the aging population increasing, there is greater emphasis on delivering efficient, patient-centered care; hence, demand for CIS platforms that support the healthcare needs of the geriatric population is expected to see a significant rise.
Growing Emphasis of Key Players Launch of New Platforms for Healthcare Industry Anticipates the Market Growth
The increasing focus of major players on introducing new CIS platforms acts as a strong force for market growth, as it continuously drives innovation and expands the functionalities of CIS. Companies are focused on developing advanced, user-friendly platforms by integrating advanced technologies, including machine learning, and cloud computing, into their data management, patient care, and decision-making. These innovations make CIS platforms more efficient, scalable, and adaptable to various settings of healthcare, which attracts a wider variety of healthcare providers.
Moreover, new CIS solutions launched in the market address emerging needs, such as interoperability, data security, and remote patient monitoring, which are very essential in managing chronic conditions and providing connected care.
For instance, in March 2023, Fujitsu, information and communication technology company launched a new cloud based technology platform that allows healthcare users to securely collect health-related data for promoting digital transformation in medical field. This health-related data includes clinical data from electronic medical records, and medical practices.
Key players contribute to increased adoption by continuously enhancing features and solving specific healthcare challenges, which helps the market grow. In the end, new CIS platforms help in strengthening healthcare delivery and drive overall growth by meeting the demands of both healthcare providers and patients.
Emphasis on Improving Interoperability among Healthcare Organizations can bring new business Opportunities
Growing focus by major players on enhancing interoperability between healthcare providers through CIS presents tremendous new business opportunities and avenues for differentiation. Interoperability makes it easier to share patient data across the continuum of care, from hospitals and clinics to specialists, and vice versa, irrespective of geographical locations or different systems. This capability addresses one of the most significant challenges in healthcare which hinders coordinated care.
Companies focusing on developing CIS solutions that improve interoperability to enable healthcare organizations to access and share patient data more efficiently, improve clinical workflows, enhance care coordination, and reduce medical errors can lead to better patient outcomes with reduced operational costs.
For CIS providers, the ability to provide superior interoperability means a real competitive advantage, as their systems then become indispensable for organizations that want to solve their regulatory requirements and service provision challenges.
Companies that develop solutions for integration across multiple platforms, by standards of data and collaboration improvement among the teams of healthcare, will find themselves in a better place to attract more customers, and have an extended market share.
Principal Consultant
Dependency of healthcare organizations on digital systems for managing patient data put them on higher risk of data breaches. These factor is one of the significant barriers to the growth of clinical information systems (CIS) in healthcare.
For instance, according to an article published by HIPAA Journal in November 2024, around 5,887 large healthcare data breaches were reported the USA.
These breaches not only leak sensitive information but also result in legal and financial implications which could cost them a penalty of USD 1.5 million a year. Besides, healthcare data is often shared across several systems, and consistent and secure data exchange remains a challenge. Most of the legacy systems still lack the required security protocols that are necessary for protecting sensitive information.
Therefore, the financial burden of compliance, the need for constant upgrades to combat evolving cyber threats, and the potential loss of patient trust contribute to the slower adoption of clinical information system in the market.
The global clinical information system industry recorded a CAGR of 7.4% during the historical period between 2019 and 2023. The growth of clinical information system industry was positive as it reached a value of USD 1,117.6 million in 2023 from USD 736.6 million in 2019.
CIS is an integrated electronic system used by a healthcare organization for maintaining and managing all the patient-related information, clinical processes, and clinical workflows. It integrates main healthcare functionalities, including EHRs, laboratory results, patient history, and treatment plans for healthcare providers to make informed decisions and facilitate easy operations, leading to quality patient care. CIS in healthcare provides storing, retrieving, and sharing of information about the patient effectively for better patient care with reduced errors.
Growing demand for effective treatment, regulatory requirements such as the Health Information Technology for Economic and Clinical Health Act, along with growing demands for decision-making based on the analytics and interpretation of Big Data-these have significantly contributed to its adoption. Moreover, the increase in chronic diseases, emphasis on cost efficiencies of healthcare, and interest in ensuring higher levels of patient involvement also accelerate the demand for solutions concerning CIS.
Integration of predictive analytics, enhanced decision support, and personalized treatment plans are few of the recent advancements in the CIS systems. The cloud-based solutions also improved access, scalability, and security of data.
Increasing interoperability, the growing adoption of telehealth, and the demand for personalized, patient-centered care are some of the factors driving the growth of the CIS market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 63.6% in global market. These market leaders are characterized by high production capacity and a wide product portfolio. These market leaders are distinguished by their extensive expertise, broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series utilizing latest technology and meeting regulatory standards required for highest quality. Prominent companies within tier 1 include Epic, Heathland, Cerner Corporation, Allegro CTMS and Athena health.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 24.5% market share. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Allegro CTMS, Practice Fusion, Inc., Accenture, and Clinicmaster
Finally, Tier 3 companies, act as a suppliers to the established market players. They are essential for the market as they specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the clinical information system market remains dynamic and competitive.
The section below covers the industry analysis for the clinical information system market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The USA is anticipated to remain at the forefront in North America, anticipating to grow at a CAGR of 3.0% through 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| UK | 3.4% |
| China | 9.5% |
| Japan | 3.9% |
| South Korea | 7.5% |
| Australia | 4.4% |
| France | 4.8% |
| Germany | 3.0% |
USA Clinical Information System market is poised to exhibit a CAGR of 3.0% between 2024 and 2034, and is projected to generate significant revenue during to the forecast period.
The rise in the number of players concentrating on new product launches of CIS contributes much to the growth in the United States. As competition mounts, companies are launching newer and more innovative CIS solutions to handle the changing needs of healthcare organizations. These new products are often more appealing to healthcare providers.
Key players are incorporating cloud-based platforms to enhance the systems for better efficiency, scalability, and accessibility. New products are also designed to meet regulatory standards, which means that health organizations can meet compliance matters.
For instance, in July 2023, Clinisys, Inc., launched Clinisys Laboratory Solutions to the market. Moreover, with more entrants selling specialized offerings, the USA healthcare sector benefits in terms of a wider range of solutions being offered, therefore encouraging expansion and technological changes in the market.
Japan currently holds a significant share of the market and is projected to grow at a CAGR of 3.9% during the forecast period.
Strategic partnerships of CIS companies with medical universities in Japan act as a driver for the growth of the CIS market. These strategic partnerships lay the foundation for the development of sophisticated technologies in CIS that are very specific to healthcare providers and medical education.
Very often, universities become places for field testing of new systems and provide substantial feedback, which is important for the improvement of products. Such collaboration stimulates innovation in medical training using the CIS tools for training future professionals in healthcare. For instance, in January 2023, Fujitsu collaborated with Sapporo Medical University, for launch of new joint project on data portability in healthcare field.
These collaborations, therefore, accelerate the adoption of sophisticated CIS platforms across Japan's healthcare system, thereby driving market growth and enhancing the quality of care provided to patients.
Australia is expected to have a strong foothold in the market which is anticipated to grow at a CAGR of almost 3.0% during the forecast period.
The Australian Digital Health Agency has launched the Allied Health Clinical Information System (CIS) Connections to My Health Record. The initiative encourages increased integration of allied health professionals, especially those involved in chronic disease management and multidisciplinary care, into the My Health Record system for a more connected, digital healthcare infrastructure.
This enable a digital integration which allows safe sharing of patient data, enabling communication and coordination among providers of care efficiently. Electronic prescribing further enables efficiency and accuracy of treatment, reducing the risk of errors.
The more the allied health software providers adhere to the standards of My Health Record, the more CIS/EMR solutions will be developed. This will thus play a critical role in the digitalization of Australia's health system and serve to boost patient outcomes while supporting overall growth within the CIS solutions.
The section contains information about the leading segments in the industry. By solution, the outpatient clinical information system segment is estimated to hold an optimum share of the market and is projected to grow at a significant growth rate throughout 2034.
| Solution | Outpatient Clinical Information Systems |
|---|---|
| Value Share (2024) | 34.6% |
The outpatient segment dominate the clinical information system (CIS) market owing to several reasons such as higher number of outpatient visits. These systems are designed to meet the particular needs of outpatient services like appointment scheduling, tracking patients, and treatment management.
Additionally, the outpatient CIS solutions are very cost-effective and allow small-scale health practices to implement efficient operation, reduction in errors, and enhance care for patients within a reasonable budget. Increasing demands for more accessible and efficient health services have also encouraged the adoption of outpatient CIS as these systems smoothen the workflow and enable providers to give personalized care in service delivery.
Such advances in technology include cloud-based platforms and mobile solutions, making outpatient CIS more scalable, flexible, and accessible. As healthcare continues to shift toward outpatient settings, the growth of outpatient CIS remains one of the key trends in the overall Clinical Information Systems market.
| Deployment | Cloud Based |
|---|---|
| Value Share (2034) | 63.6% |
The cloud-based segment is forecasted to account for highest share of the market and is anticipated to grow at a significant CAGR during the forecast period.
Cloud-based CIS holds the highest share of the market owing to its several advantages such as its cost-effective nature. These solutions eliminate the need for installation of expensive on-site infrastructure, hardware, and the cost required for maintaining and updating these systems. These factors make it one of the more viable option for healthcare organizations, especially those are working at smaller capacities.
Moreover, Cloud-based CIS platforms can easily scale to the needs of growing healthcare organizations and are able to expand patient volume, add new locations, or integrate with additional systems. This flexibility allows providers to adapt to changing demands with minimal disruption.
These systems also allows healthcare providers to access patient data from any location. Many providers implement robust encryption and backup protocols that help in ensuring sensitive patient data is protected and meets industry standards such as HIPAA. These benefits collectively contribute to the dominance of cloud-based CIS in the market.
Substantial investments are seen in the clinical information system industry towards research and development in order to drive innovations. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Clinical Information System Market:
In terms of Solution, the industry is divided into outpatient clinical information systems, inpatient clinical information systems, specialty clinical information systems and ancillary information systems.
In terms of Services, the industry is segregated into consulting services and managed services
The industry is classified by deployment into cloud based and on-premise
In terms of access/platform, the industry is segmented into Mobiles/Smart Phones and Desktop/Laptops
The industry is classified by end user as healthcare facilities and payers
Key countries of North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa (MEA) have been covered in the report.
The global clinical information system industry is projected to witness CAGR of 8.0% between 2024 and 2034.
The global clinical information system industry stood at USD 1,117.6 million in 2023.
The global clinical information system industry is anticipated to reach USD 2,412.8 million by 2034 end.
Japan is set to record the highest CAGR of 7.8% in the assessment period.
The key players operating in the global clinical information system industry include Medical Information Technology, Inc, eClinicalWorks, Systematic A/S, Epic Systems Corporation, Orion Health, Clintel Systems, Haitai Medical Information Systems Co., Ltd, PCCW Solutions Limited, Medicalsystem Co., Ltd., 3M Health Information Systems, Systematic A/S, Allscripts Healthcare Solutions, Inc, TELUS, INFINITT North America Inc etc.
Healthcare
June 2024
REP-GB-14775
250 pages
Explore Healthcare Insights
View Reports
Clinical Information System Market
